| Target Price | $224.40 |
| Price | $207.54 |
| Potential |
8.12%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Cardinal Health 2026 .
The average Cardinal Health target price is $224.40.
This is
8.12%
register free of charge
$243.60
17.37%
register free of charge
$153.63
25.98%
register free of charge
|
|
| A rating was issued by 21 analysts: 17 Analysts recommend Cardinal Health to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cardinal Health stock has an average upside potential 2026 of
8.12%
register free of charge
|
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 222.58 | 259.52 |
| 1.87% | 16.60% | |
| EBITDA Margin | 1.25% | 1.51% |
| 17.61% | 20.64% | |
| Net Margin | 0.70% | 0.91% |
| 86.71% | 29.75% |
18 Analysts have issued a sales forecast Cardinal Health 2026 . The average Cardinal Health sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Cardinal Health EBITDA forecast 2026. The average Cardinal Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
18 Cardinal Health Analysts have issued a net profit forecast 2026. The average Cardinal Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 6.45 | 9.93 |
| 86.96% | 53.95% | |
| P/E | 20.91 | |
| EV/Sales | 0.21 |
18 Analysts have issued a Cardinal Health forecast for earnings per share. The average Cardinal Health EPS is
This results in the following potential growth metrics and future valuations:
Cardinal Health...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Locked
➜
Locked
|
Locked | Dec 09 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Nov 03 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Oct 31 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 31 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Oct 31 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barclays:
Locked
➜
Locked
|
Dec 09 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Nov 03 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Oct 31 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 31 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Oct 31 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


